-
-
News
News Highlights
- Books
Featured Books
- smt007 Magazine
Latest Issues
Current IssueDo You Have X-ray Vision?
Has X-ray’s time finally come in electronics manufacturing? Join us in this issue of SMT007 Magazine, where we answer this question and others to bring more efficiency to your bottom line.
IPC APEX EXPO 2025: A Preview
It’s that time again. If you’re going to Anaheim for IPC APEX EXPO 2025, we’ll see you there. In the meantime, consider this issue of SMT007 Magazine to be your golden ticket to planning the show.
Technical Resources
Key industry organizations–all with knowledge sharing as a part of their mission–share their technical repositories in this issue of SMT007 Magazine. Where can you find information critical to your work? Odds are, right here.
- Articles
- Columns
Search Console
- Links
- Media kit
||| MENU - smt007 Magazine
OSI Systems Reports Fiscal 2022 Fourth Quarter and Full Year Financial Results
August 19, 2022 | Business WireEstimated reading time: 4 minutes

OSI Systems, Inc. announced financial results for the fourth quarter and fiscal year ended June 30, 2022.
Deepak Chopra, OSI Systems’ Chairman and Chief Executive Officer, stated “We are pleased to conclude fiscal 2022 with record fourth quarter and full-year revenues and adjusted earnings per share despite continued global economic uncertainty characterized by supply chain challenges, inflationary pressure, and rising interest rates. With strong bookings, we enter our new fiscal year with significant backlog and a robust pipeline of opportunities to enable us to maintain our positive momentum.”
For the fourth quarter of fiscal 2022 the Company reported revenues of $336.8 million, 1% higher than the $332.2 million reported for the fourth quarter of fiscal 2021. Net income for the fourth quarter of fiscal 2022 was $33.8 million, or $1.94 per diluted share, compared to net income of $25.9 million, or $1.40 per diluted share, for the fourth quarter of fiscal 2021. Non-GAAP net income for the fourth quarter of fiscal 2022 was $34.0 million, or $1.96 per diluted share, compared to non-GAAP net income for the fourth quarter of fiscal 2021 of $28.5 million, or $1.54 per diluted share.
For the fiscal year ended June 30, 2022, revenues increased by 3% to $1.183 billion from $1.147 billion in the prior fiscal year. Net income for fiscal 2022 was $115.3 million, or $6.45 per diluted share, compared to net income of $74.0 million, or $4.03 per diluted share, in the prior fiscal year. Non-GAAP net income for the fiscal year ended June 30, 2022 was $103.8 million, or $5.81 per diluted share, compared to non-GAAP net income of $97.9 million, or $5.32 per diluted share, for the 2021 fiscal year.
Mr. Chopra commented, “The Security division finished the fiscal year with record fourth quarter revenues and operating income despite continued challenges, including the impact of higher supply chain and logistics costs, and rising labor costs. The Security division reported a 4% year-over-year increase in fourth quarter revenues and significantly expanded its adjusted operating margin, driven by robust activity across multiple geographic channels. With our strong fiscal 2022 book-to-bill ratio, we enter the new fiscal year with significant backlog in our Security division.”
Mr. Chopra continued, “Our Optoelectronics and Manufacturing division again delivered solid fourth quarter financial results posting significant operating margin expansion along with solid bookings leading to a record backlog for the division. The division has benefitted from our vertically-integrated manufacturing global footprint and performed exceptionally well ending the fiscal year with record revenues, record operating income, and record bookings, positioning us well as we enter fiscal 2023.”
Mr. Chopra concluded, “Our Healthcare division, as anticipated, reported a relatively small reduction in revenues for the fourth quarter of fiscal 2022 in comparison to the same prior-year period, which had been bolstered during the earlier stages of the COVID pandemic. During the quarter, we continued to focus on new product development, principally in our patient monitoring portfolio, to enhance our core offerings.”
The effective tax rate for the fourth quarter of fiscal 2022 was 9.0%, compared with 12.9% in the prior year fourth quarter. The Company recognized a net discrete income tax benefit of $4.9 million during the fourth quarter of fiscal 2022 compared to $4.0 million in the comparable prior year quarter. Excluding the net discrete income tax items in both periods, the effective tax rates would have been 22.3% and 26.3%, respectively, for the three months ended June 30, 2022 and 2021.
During the three months and fiscal year ended June 30, 2022, the Company's book-to-bill ratio was 1.0 and 1.1, respectively. As of June 30, 2022, the Company's backlog was $1.2 billion, representing an increase of 15% from the Company’s backlog as of the end of the last fiscal year. During the quarter ended June 30, 2022, operating cash flow was $22.0 million, and capital expenditures were $4.6 million.
Alan Edrick, Executive Vice President and Chief Financial Officer, stated, “Overall, we were pleased with our fourth quarter and fiscal year 2022 financial results. In the face of continuing supply chain constraints throughout fiscal 2022, we invested in working capital, including maintaining higher inventory levels, which enabled us to be nimble and responsive to our customers in a difficult environment.”
Mr. Edrick continued, “We continued to be active in our stock repurchase program and acquired 177,336 shares during the fourth quarter of fiscal 2022. During fiscal 2022, in aggregate, we repurchased approximately 7% of our outstanding shares as part of our capital allocation strategy, leaving us with the ability to repurchase approximately 1.25 million additional shares under our current buyback program. In the near term, we expect to utilize our credit facility to repay the remaining outstanding balance of our convertible notes maturing in September 2022.”
Fiscal Year 2023 Outlook
For fiscal year 2023, the Company anticipates revenues in the range of $1.240 billion to $1.275 billion and adjusted earnings per diluted share in the range of $6.02 to $6.25. This guidance reflects significantly higher expected interest expense due to the rising interest rate environment coupled with the maturity of the Company’s 1.25% convertible notes. Actual revenues and adjusted diluted earnings per share could vary from this guidance due to factors discussed under “Forward-Looking Statements” or other factors.
The Company’s fiscal 2023 diluted earnings per share guidance is provided on a non-GAAP basis only. The Company does not provide a reconciliation of guidance for adjusted diluted EPS to GAAP diluted EPS (the most directly comparable GAAP measure) on a forward-looking basis because the Company is unable to provide a meaningful or accurate compilation of reconciling items and certain information is not available. This is due to the inherent difficulty and complexity in accurately forecasting the timing and amounts of various items included in the calculation of GAAP diluted EPS but excluded in the calculation of adjusted diluted EPS, such as acquisition costs and other non-recurring items that have not yet occurred, are out of the Company’s control, or cannot otherwise reasonably be predicted. For the same reasons, the Company is unable to address the significance of unavailable information which may be material and therefore could result in GAAP diluted EPS, the most directly comparable GAAP financial measure, being materially different from projected adjusted diluted EPS.
Suggested Items
Kitron: Q1 2025 - Strong Start to the Year
04/25/2025 | KitronKitron reported first-quarter results characterised by continued momentum in the Defence & Aerospace market sector and a growing order backlog.
Element Solutions Inc Announces 2025 First Quarter Financial Results
04/25/2025 | BUSINESS WIREElement Solutions Inc., a global and diversified specialty chemicals company, announced its financial results for the three months ended March 31, 2025.
Mycronic Posts Interim Report January-March 2025
04/25/2025 | MycronicMycronic announced its interim report for the period of January to March 2025, revealing a strong performance in the first quarter. The company reported significant increases in order intake and net sales, alongside a healthy EBIT margin.
Saab Receives Order for Additional Live Training Equipment from U.S. Marine Corps
04/15/2025 | SaabSaab has received a contract modification award from the U.S. Marine Corps for additional Marine Corps Training Instrumentation Systems (MCTIS) equipment.
Cicor Reports Double-Digit Growth Driven by Integration & M&A
04/15/2025 | CicorThe Cicor Group has made a successful start to the 2025 business year. In the first quarter, sales increased by 22.2 % to CHF 131.1 million (Q1/2024: CHF 107.3 million), while order intake increased by 29.1 % year-on-year to CHF 125.8 million.